These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29691252)

  • 1. High USP6NL Levels in Breast Cancer Sustain Chronic AKT Phosphorylation and GLUT1 Stability Fueling Aerobic Glycolysis.
    Avanzato D; Pupo E; Ducano N; Isella C; Bertalot G; Luise C; Pece S; Bruna A; Rueda OM; Caldas C; Di Fiore PP; Sapino A; Lanzetti L
    Cancer Res; 2018 Jul; 78(13):3432-3444. PubMed ID: 29691252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.
    Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG
    Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
    Makinoshima H; Takita M; Saruwatari K; Umemura S; Obata Y; Ishii G; Matsumoto S; Sugiyama E; Ochiai A; Abe R; Goto K; Esumi H; Tsuchihara K
    J Biol Chem; 2015 Jul; 290(28):17495-504. PubMed ID: 26023239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP6NL mediated by LINC00689/miR-142-3p promotes the development of triple-negative breast cancer.
    Ma T; Liu H; Liu Y; Liu T; Wang H; Qiao F; Song L; Zhang L
    BMC Cancer; 2020 Oct; 20(1):998. PubMed ID: 33054738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATM inhibitor KU-55933 induces apoptosis and inhibits motility by blocking GLUT1-mediated glucose uptake in aggressive cancer cells with sustained activation of Akt.
    Harris BRE; Zhang Y; Tao J; Shen R; Zhao X; Cleary MP; Wang T; Yang DQ
    FASEB J; 2021 Apr; 35(4):e21264. PubMed ID: 33715230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation.
    Lee JH; Liu R; Li J; Wang Y; Tan L; Li XJ; Qian X; Zhang C; Xia Y; Xu D; Guo W; Ding Z; Du L; Zheng Y; Chen Q; Lorenzi PL; Mills GB; Jiang T; Lu Z
    Mol Cell; 2018 Apr; 70(2):197-210.e7. PubMed ID: 29677490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP1-TEAD1-Glut1 axis dictates the oncogenic phenotypes of breast cancer cells by modulating glycolysis.
    Lin C; Xu X
    Biomed Pharmacother; 2017 Nov; 95():789-794. PubMed ID: 28892790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia Alters the Response to Anti-EGFR Therapy by Regulating EGFR Expression and Downstream Signaling in a DNA Methylation-Specific and HIF-Dependent Manner.
    Mamo M; Ye IC; DiGiacomo JW; Park JY; Downs B; Gilkes DM
    Cancer Res; 2020 Nov; 80(22):4998-5010. PubMed ID: 33023947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK.
    Schmidt M; Voelker HU; Kapp M; Krockenberger M; Dietl J; Kammerer U
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):219-25. PubMed ID: 19655166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. t-Darpp Activates IGF-1R Signaling to Regulate Glucose Metabolism in Trastuzumab-Resistant Breast Cancer Cells.
    Lenz G; Hamilton A; Geng S; Hong T; Kalkum M; Momand J; Kane SE; Huss JM
    Clin Cancer Res; 2018 Mar; 24(5):1216-1226. PubMed ID: 29180608
    [No Abstract]   [Full Text] [Related]  

  • 11. CXADR-Mediated Formation of an AKT Inhibitory Signalosome at Tight Junctions Controls Epithelial-Mesenchymal Plasticity in Breast Cancer.
    Nilchian A; Johansson J; Ghalali A; Asanin ST; Santiago A; Rosencrantz O; Sollerbrant K; Vincent CT; Sund M; Stenius U; Fuxe J
    Cancer Res; 2019 Jan; 79(1):47-60. PubMed ID: 30385615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt substrate TBC1D1 regulates GLUT1 expression through the mTOR pathway in 3T3-L1 adipocytes.
    Zhou QL; Jiang ZY; Holik J; Chawla A; Hagan GN; Leszyk J; Czech MP
    Biochem J; 2008 May; 411(3):647-55. PubMed ID: 18215134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis.
    Liu T; Kishton RJ; Macintyre AN; Gerriets VA; Xiang H; Liu X; Abel ED; Rizzieri D; Locasale JW; Rathmell JC
    Cell Death Dis; 2014 Oct; 5(10):e1470. PubMed ID: 25321477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol Induces Epithelial-to-Mesenchymal Transition of Prostate Cancer Cells by Suppressing Degradation of EGFR through APMAP.
    Jiang S; Wang X; Song D; Liu X; Gu Y; Xu Z; Wang X; Zhang X; Ye Q; Tong Z; Yan B; Yu J; Chen Y; Sun M; Wang Y; Gao S
    Cancer Res; 2019 Jun; 79(12):3063-3075. PubMed ID: 30987997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WNK1 phosphorylation sites in TBC1D1 and TBC1D4 modulate cell surface expression of GLUT1.
    Henriques AFA; Matos P; Carvalho AS; Azkargorta M; Elortza F; Matthiesen R; Jordan P
    Arch Biochem Biophys; 2020 Jan; 679():108223. PubMed ID: 31816312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGF receptor stimulation shifts breast cancer cell glucose metabolism toward glycolytic flux through PI3 kinase signaling.
    Jung KH; Lee EJ; Park JW; Lee JH; Moon SH; Cho YS; Lee KH
    PLoS One; 2019; 14(9):e0221294. PubMed ID: 31532771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling.
    Sun K; Tang S; Hou Y; Xi L; Chen Y; Yin J; Peng M; Zhao M; Cui X; Liu M
    EBioMedicine; 2019 Mar; 41():370-383. PubMed ID: 30799198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer.
    Wang J; Ji H; Niu X; Yin L; Wang Y; Gu Y; Li D; Zhang H; Lu M; Zhang F; Zhang Q
    Dis Markers; 2020; 2020():6103542. PubMed ID: 32377271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic phenotype of bladder cancer.
    Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
    Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A2 promotes glycolysis and proliferation via GLUT1 regulation in colorectal cancer.
    Li C; Chen Q; Zhou Y; Niu Y; Wang X; Li X; Zheng H; Wei T; Zhao L; Gao H
    FASEB J; 2020 Oct; 34(10):13333-13344. PubMed ID: 32816365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.